Shortened Regimen for Drug-susceptible TB in Children | MicrobiomeTrials← Back to trialsNCT06253715
Shortened Regimen for Drug-susceptible TB in Children
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-01-15Est. Completion: 2027-09-30
Enrollment target: 860 participants Locations- Indian Council of Medical Research - National Institute for Research in Tuberculosis, Chennai, India
- Dr. D.Y. Patil Medical College, Hospital and Research Center, Pune, India
- Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
- Instituto Nacional de Saúde (INS), Maputo, Mozambique
- Africa Health Research Institute (AHRI), Durban, South Africa
- MU-JHU Care Ltd, Kampala, Uganda
- University of Zambia, School of Medicine, Lusaka, Zambia
- Arthur Davison Children's Hospital, Ndola, Zambia
- Harare Health and Research Consortium (HHRC), Harare, Zimbabwe
Other microbiome trials you might be interested in
Ulcerative ColitisCrohn's Disease
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (C…
Cambridge, United StatesEst. completion Dec 15, 2026
HIV-1-infection
Phase III trial evaluating doravirine as an alternative to dolutegravir in treatment naïve people living with HIV-1 infe…
Nova Iguaçu, BrazilEst. completion Jan 2028